Advertisement

Neurotoxic Agents Interacting with the Muscarinic Acetylcholine Receptor

  • J. Järv
Part of the Springer Study Edition book series (volume 102)

Abstract

The neurotransmitter acetylcholine (ACh) exerts two types of effects, differing, in their location and in the nature of the associated physiological responses and pharmacology (Dale 1914). These observations have led to the definition of two major types of ACh receptors, specified as nicotinic and muscarinic because their characteristic responses can be evoked by nicotine and muscarine, respectively (Michaelson and Zeimal 1973).

Keywords

Muscarinic Receptor Muscarinic Acetylcholine Receptor Muscarinic Agonist Muscarinic Antagonist Neurotoxic Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abramson FB, Barlow RB, Mustafa MG, Stephenson RP (1969) Relationships between chemical structure and affinity for acetylcholine receptors. Br J Pharmacol 37:207–233PubMedGoogle Scholar
  2. Abramson FB, Barlow RB, Franks FM, Pearson FBM (1974) Relationships between chemical structure and affinity for postganglionic acetylcholine receptors of the guinea-pig ileum. Br J Pharmacol 51:81–93PubMedGoogle Scholar
  3. Adem A, Asblom A, Johansson G, Mbugua PM, Karlsson E (1988) Toxins from the venom of the green mamba Dendroaspis angusticeps that inhibit the binding of quinuclidinyl benzilate to muscarinic acetylcholine receptors. Biochim Biophys Acta 968:340–345PubMedCrossRefGoogle Scholar
  4. Angeli P, Gianella M, Pigini M (1984) Size of muscarinic receptor anionic binding site related to onium group of ligands with a 1,3-oxathiolane nucleus. Eur J Med Chem 19:495–500Google Scholar
  5. Aronstam RS, Abood LG, MacNeil MK (1977) Muscarinic cholinergic binding in human erythrocyte membranes. Life Sci 20:1175–1180PubMedCrossRefGoogle Scholar
  6. Baker RW, Chotia CH, Pauling P, Petcher TJ (1971) Structure and activity of muscarinic stimulants. Nature 230:439–445PubMedCrossRefGoogle Scholar
  7. Barlow B, Scott KA, Stephenson RP (1963) An attempt to study the effects of chemical structure on the affinity and efficacy of compounds related to acetylcholine. Br J Pharmacol 21:509–522Google Scholar
  8. Baumgold J, Abood LG, Hoss WP (1975) Chemical factors influencing the psychomimetic potency of glycolate esters. Life Sci 17:603–612PubMedCrossRefGoogle Scholar
  9. Bebbington A, Brimblecombe RW, Shekeshaft D (1966) The central and peripheral activity of acetylenic amines related to oxotrèmorine. Br J Pharmacol 26:56–67Google Scholar
  10. Becker CE, Tong TG, Boerner U, Roe RL, Scott RAT, MacQuarrie MB, Bartter F (1979) Diagnosis and treatment of Amanita phalloides type mushroom poisoning. West J Med 125:100–109Google Scholar
  11. Beckett AH (1967) Stereospecificity in reactions of cholinesterases and the cholinergic receptor. Ann NY Acad Sci 144:675–688CrossRefGoogle Scholar
  12. Beckett AH, Harper NJ, Cliterow JW (1963) The absolute configurations of the alfa- and beta-methylcholine isomers and their acetyl and succinyl esters. J Pharm Pharmacol 15:349–355PubMedCrossRefGoogle Scholar
  13. Bevan P (1984) [3H]Oxotremorine-M binding to membrances prepared from rat brain and heart: evidence for subtypes of muscarinic receptors. J Eur Pharmacol 101:101–110CrossRefGoogle Scholar
  14. Birdsall NJM, Burgen ASV, Hulme EC (1978) Binding of agonists to brain muscarinic receptors. Mol Pharmacol 14:723–736PubMedGoogle Scholar
  15. Birdsall NJM, Hulme EC, Burgen ASV (1980) The character of muscarinic receptors in different regions of the rat brain. Proc R Soc Lond [Biol] 207(1166): 1–12CrossRefGoogle Scholar
  16. Birdsall NJM, Burgen ASV, Hulme EC, Wong EHF (1983) The effect of p- chloromercuribenzoate on structure-binding relationships of muscarinic receptors on the rat cerebral cortex. Br J Pharmacol 80:197–204PubMedGoogle Scholar
  17. Bolton TB (1979) The mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev 59:606–718PubMedGoogle Scholar
  18. Bowman WC, Bowman A (1986) Dictionary of pharmacology. Blackwell, OxfordGoogle Scholar
  19. Burgen ASV (1965) The role of ionic interaction at the muscarinic receptor. Br J Pharmacol Chemother 25:4–17PubMedGoogle Scholar
  20. Chang KJ, Triggle DJ (1973) Stereoselectivity of cholinergic activity in a series of 1,3-dioxolanes. J Med Chem 16:718–720PubMedCrossRefGoogle Scholar
  21. Clark AJ (1937) General pharmakology. Springer, Berlin (Heffter’s Handbuch der experimentellen Pharmakologie, vol 4)Google Scholar
  22. Closse A, Bittiger H, Langenegger D, Wanner A (1987) Binding studies with [3H]cis-methyldioxolane in different tissues. Naunyn Schmiedebergs Arch Pharmacol 335:372–377PubMedCrossRefGoogle Scholar
  23. Dahlbom R, Jenden DJ, Resul B, Ringdahl B (1982) Stereochemical requirements for central and peripheral muscarinic and antimuscarinic activity of some acetylenic compounds related to oxotremorine. Br J Pharmaccol 76:299–304Google Scholar
  24. Dale HH (1914) The action of certain esters and ethers of choline and their relation to muscarine. J Pharmacol 6:147–190Google Scholar
  25. Ducanel F, Rowan EG, Cassart E, Harvey AL, Menez A, Boulain J-C (1991) Aminoacid sequence of a muscarinic toxin deduced from the cDNA nucleotide sequence. Toxicon 29:No, 4/5, 516–520CrossRefGoogle Scholar
  26. Ehlert FJ (1985) The relationship between muscarinic receptor occupancy and adenylate cyclase inhibition in the rabbit myocardium. Mol Pharmacol 28:410–421PubMedGoogle Scholar
  27. Ehlert FJ, Dumont Y, Roeske WR, Yamamura HI (1980) Muscarinic receptor binding in rat brain using the agonist [3H]cis-methyldioxolane. Life Sci 26:961–967PubMedCrossRefGoogle Scholar
  28. Ehlert FJ, Roeske WR, Yamamura HI (1984) Muscarinic receptor [3H]ligand binding methods. In: Marangos PJ, Campbell IC, Cohen RM (eds) Amines and acetylcholine. Academic, Orlando, pp 339–355 (Brain receptor methodology, part A)Google Scholar
  29. Ellenbroek BWJ, Nivard RJF, van Rossum JM, Ariens EJ (1965) Absolute configuration and parasympathetic action: pharmacodynamics of enantiomor- phic and diastereoisomeric esters of beta-methylcholine. J Pharm Pharmacol 17:393–404PubMedCrossRefGoogle Scholar
  30. Eller M, Järv J (1988) Two-step isomerization of quinuclidinyl benzilate-muscarinic receptor complex. Neurochem Int 12:285–289PubMedCrossRefGoogle Scholar
  31. Eller M, Järv J (1989) Kinetics of N-methylscopolapnine interaction with muscarinic receptor from rat cerebral cortex. Neurochem Int 15:301–305PubMedCrossRefGoogle Scholar
  32. Eller M, Järv J, Palumaa P (1988) Influence of non-radioactive ligands on kinetics of N-methyl-[3H]scopolamine binding to muscarinic receptor. Org React 25:372–386Google Scholar
  33. Eller M, Järv J, Loodmaa E (1989) Kinetic analysis of interaction of ester antagonists with muscarinic receptor. Org React 26:199–210Google Scholar
  34. Ensing K, de Zeeuw RA (1986) Differential behavior toward muscarinic receptor binding between quaternary anticholinergics and their tertiary analogues. Pharmacol Res 3:327–332CrossRefGoogle Scholar
  35. Fields JZ, Roeske WR, Morkin E, Yamamura HI (1978) Cardiac muscarinic cholinergic receptors. Biochemical identification and characterization. J Biol Chem 253:3251–3258PubMedGoogle Scholar
  36. Gabrielevitz A, Kloog Y, Kalir A, Balderman D, Sokolovsky M (1980) Interaction of phencyclidine and its new adamantyl derivatives with muscarinic receptors. Life Sci 26:89–95PubMedCrossRefGoogle Scholar
  37. Gallacher DV, Morris PA (1986) A patch-clamp study of potassium currents in resting and acetylcholine-stimulated mouse submandibular acinar cells. J Physiol (Lond) 373:379–395Google Scholar
  38. Galper JB, Klein N, Catterall WA (1977) Muscarinic acetylcholine receptors in developing chick heart. J Biol Chem 252:8692–8699PubMedGoogle Scholar
  39. Gibson RE, Rzeszotarski WJ, Jagoda EM, Francis BE, Reba RC, Eckelman WC (1984) [125I]3-quinuclidinyl-4-iodobenzilate: a high affinity high specific activity radioligand for the Ml and M2 acetylcholine receptors. Life Sci 34:2287–2296PubMedCrossRefGoogle Scholar
  40. Gurwitz D, Kloog Y, Sokolovsky M (1984) Recognition of the muscarinic receptor by its endogenous transmitter: binding of [3H]acetylcholine and its modulation by Transltion metal ions and guanine nucleotide. Proc Natl Acad Sci USA 81:3650–3654PubMedCrossRefGoogle Scholar
  41. Gurwitz D, Kloog Y, Sokolovsky M (1985) High affinity binding of [3H]acetylcholine to muscarinic receptors: regional distribution and modulation by guanine nucleotides. Mol Pharmacol 28:295–297Google Scholar
  42. Haga K, Haga T, Ichiyama A, Katada T, Kurose H, Ui M (1985) Functional reconstruction of purified muscarinic receptors and inhibitory guanine nucleotide regulatory protein. Nature 316:731–733PubMedCrossRefGoogle Scholar
  43. Haga K, Haga T, Ichiyama A (1986) Reconstitution of the muscarinic acetylcholine receptor: guanine nucleotide-sensitive high affinity binding of agonists to purified muscarinic receptors reconstituted with GTP-binding proteins (Gi and Go). J Biol Chem 261:10133–10140PubMedGoogle Scholar
  44. Hansch C, Leo A (1979) Substituent constants for correlation analysis in chemistry and biology. Wiley, New YorkGoogle Scholar
  45. Harden TK, Meeker RB, Martin MW (1983) Interaction of radiolabelled agonist with cardiac muscarinic cholinergic receptors. Pharmacol Exp Ther 227:570–577Google Scholar
  46. Hedlund B, Bartfai T (1981) Binding of 3H-pilocarpine to membranes from rat cerebral cortex. Naunyn Scmiedebergs Arch Pharmacol 317:126–130CrossRefGoogle Scholar
  47. Heilbronn E, Bartfai T (1978) Muscarinic acetylcholine receptor. Prog Neurobiol 11:171–188PubMedCrossRefGoogle Scholar
  48. Heiser JF, Hillin JC (1971) The reversal of anticholinergic drug induced delirium and coma with physiostigmine. Am J Psychiatry 127:1050–1052PubMedGoogle Scholar
  49. Hrdina PD (1986) General principles of receptor binding. In: Boulton AA, Baker GB, Hrdina PD (eds) Neuromethods. Humana, Clifton, pp 1–21Google Scholar
  50. Hulme EC, Birdsall NJM, Burgen ASV, Mehta P (1978) The binding of antagonists to brain muscarinic receptors. Mol Pharmacol 14:737–750PubMedGoogle Scholar
  51. Hurko O (1978) Specific [3H]-quinuclidinyl benzilate binding activity in digitonin- solubilized preparations from bovine brain. Arch Biochem Biophys 190:434–445PubMedCrossRefGoogle Scholar
  52. Ing HR (1949) The structure-action relationships of the choline group. Science 109:264–266PubMedCrossRefGoogle Scholar
  53. Järv J, Bartfai T (1982) The importance of hydrophobic interactions in the antagonist binding to the muscarinic acetylcholine receptor. Acta Chem Scand [B] 36: 489–498Google Scholar
  54. Järv J, Bartfai T (1988) Muscarinic acetylcholine receptor. In: Whittaker VP (ed) The cholinergic synapse. Springer, Berlin Heidelberg New York, pp 315–345 (Handbook of experimental pharmacology, vol 86)CrossRefGoogle Scholar
  55. Järv J, Eller M (1988) Kinetic aspects of L-quinuclidinyl benzilate interaction with muscarinic receptor. Neurochem Int 13:419–428PubMedCrossRefGoogle Scholar
  56. Järv J, Eller M (1989) Effect of ligand volume on affinity of muscarinic antagonists. Org React 26:188–198Google Scholar
  57. Järv J, Hedlund B, Bartfai T (1979) Isomerization of the muscarinic receptor- antagonist complex. J Biol Chem 254:5595–5598PubMedGoogle Scholar
  58. Järv J, Hedlund B, Bartfai T (1980) Kinetic studies on muscarinic antagonist-agonist competition. J Biol Chem 255:2649–2651PubMedGoogle Scholar
  59. Järv J, Sillard R, Bartfai T (1987) Influence of temperature on cooperative binding of N-methylpiperidinyl benzilate with muscarinic receptor from rat cerebral cortex. Chemistry 36:172–180Google Scholar
  60. Jencks WP (1969) Catalysis in chemistry and enzymology. McGraw-Hill, New YorkGoogle Scholar
  61. Jim K, Bolger GT, Triggle DJ (1982) Muscarinic receptors in guinea pig ileum. A study by agonist-[3H]labelled antagonist competition. Can J Physiol Pharmacol 60:1707–1714PubMedCrossRefGoogle Scholar
  62. Karlsson E (1979) Chemistry of protein toxins in snake venoms. In: Lee CY (ed) Snake venoms. Springer, Berlin Heidelberg New York, pp 259–276 (Handbook of experimental pharmacology, vol 52)CrossRefGoogle Scholar
  63. Karlsson E, Risinger C, Jolkkonen M, Wernstedt C, Adem A (1990) Amino acid sequence of a snake venom toxin that binds to the muscarinic acetylcholine receptor. Toxicon 29:521–528CrossRefGoogle Scholar
  64. Kier LB, Hall LH (1978) Molecular study of muscarinic receptor affinity of acetylcholine antagonists. J Pharm Sci 67:1408–1412PubMedCrossRefGoogle Scholar
  65. Kloog Y, Sokolovsky M (1978) Studies on muscarinic AChR from mouse brain: characterization of the interaction with antagonists. Brain Res 144:31–48PubMedCrossRefGoogle Scholar
  66. Kloog Y, Egozi Y, Sokolovsky M (1979) Characterization of muscarinic acetylcholine receptors from mouse brain: evidence for regional heterogeneity and isomerization. Mol Pharmacol 15:545–558PubMedGoogle Scholar
  67. Laduron PM, Verwimp M, Leysen JE (1979) Stereospecific in vitro binding of [3H]dexetimide to brain muscarinic receptors. J Neurochem 32:421–427PubMedCrossRefGoogle Scholar
  68. Lambrecht G (1976) Struktur- und Konformationswirkungs-Beziehungen heterocyclischer Acetylcholinanaloge. I Muscarinwirkung enantiomerer 3-Acetoxy- chinuclidine und 3-Acetooxypiperidine. Eur J Med Chem 11:461–466Google Scholar
  69. Löffelholz K, Pappano AJ (1985) The parasympathetic neuroeffector junction of the heart. Pharmacol Rev 37:1–24PubMedGoogle Scholar
  70. Lopker A, Abood LG, Hoss W, Lionetti FJ (1980) Stereoselective muscarinic acetylcholine and opiate receptors in human phagocytic leucocytes. Biochem Pharmacol 29:1361–1365PubMedCrossRefGoogle Scholar
  71. Luthin GR, Wolfe BB (1984) [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to brain muscarinic cholinergic receptors. Differences in measured receptor density are not explained by differences in receptor isomerization. Mol Pharmacol 26:164–169PubMedGoogle Scholar
  72. Maayani S, Weinstein H, Cohen S, Sokolovsky M (1973) Acetylcholine-like molecular arrangement in psychomimetic anticholinergic drugs. Proc Natl Acad Sci USA 70:3103–3107PubMedCrossRefGoogle Scholar
  73. Michaelson MJ, Zeimal EV (1973) Acetylcholine. Pergamon, New YorkGoogle Scholar
  74. Nathanson NM (1983) Binding of agonists and antagonists to muscarinic acetylcholine receptor on intact cultured heart cells. J Neurochem 41:1545–1549PubMedCrossRefGoogle Scholar
  75. Paton WDM, Rang HP (1965) The uptake of atropine and related drugs by intestinal smooth muscle of guinea pig in relation to acetylcholine receptors. Proc R Soc Lond [Biol] 163:1–44CrossRefGoogle Scholar
  76. Pratesi P, Villa L, Ferri V, de Micheli C, Grand E, Silipo C, Vittoria A (1984) Recent advances in the study of muscarinic receptor by QSAR. In: Melchirre C, Gianella M (eds) Highlights in receptor chemistry. Elsevier, Amsterdam, pp 225–250Google Scholar
  77. Rehavi M, Maayani S, Sokolovsky M (1977) Enzymatic resolution and cholinergic properties of 3-quinuclidinyl derivates. Life Sci 21:1293–1302PubMedCrossRefGoogle Scholar
  78. Resul B, Ringdahl B, Hackseil U, Svensson U, Dahlbom R (1979) Acetylenic compounds of potential pharmacological value. XXXI. Studies on N-(4-tert- amino-2-butynyl)carboxamides as muscarinic agonists. Acta Pharm Suec 16:225–232PubMedGoogle Scholar
  79. Ringdahl B, Jenden DJ (1983) Pharmacological properties of oxotremorine and its analogs. Life Sci 32:2401–2413PubMedCrossRefGoogle Scholar
  80. Rumack BH (1973) Anticholinergic poisoning: treatment with physostigmine. Pediatrics 52:449–451PubMedGoogle Scholar
  81. Schimerlik ML, Searles RP (1980) Ligand interactions with membrane bound porcine atrial muscarinic receptor(s). Biochemistry 19:3407–3413PubMedCrossRefGoogle Scholar
  82. Schmiedeberg O, Koppe R (1869) Das Muscarin, das giftige Alkaloid des Fliegenpilzes (Agaricus muscarins L.), seine Darstellung, chemischen Eigenschaften, physiologischen Wirkungen, toxikologische Bedeutung und sein Verhältnis zu Pilzvergiftungen im Allgemeinen. Vogel, LeipzigGoogle Scholar
  83. Schreiber G, Henis YI, Sokolovsky M (1985) Rate constants of agonist binding to muscarinic receptors in rat brain medulla: evaluation by competition kinetics. J Biol Chem 260:8795–8802PubMedGoogle Scholar
  84. Schulman JM, Sabio ML, Disch RL (1983) Recognition of cholinergic agonists by the muscarinic receptor. I. Acetylcholine and other agonists with the NCCOCC backbone. J Med Chem 26:817–823PubMedCrossRefGoogle Scholar
  85. Sillard RG, Järv JL, Bartfai T (1985) Kinetic evidence for cooperativity of quinuclidinyl benzilate interaction with muscarinic receptor from rat brain. Biol Membr 2:426–431Google Scholar
  86. Sokolovsky M (1984) Muscarinic receptors. Int Rev Neurobiol 25:139–183PubMedCrossRefGoogle Scholar
  87. Stephenson RP (1956) A modification of receptor theory. Br J Pharmacol 11:379–393Google Scholar
  88. Takemura S (1984) Geometry of muscarinic agonists. J Pharmacobiodyn 7:436–444PubMedCrossRefGoogle Scholar
  89. Taylor P (1980) Cholinergic agonists. In: Goodman LS, Gilman AG (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp 91–99Google Scholar
  90. Triggle DJ, Triggle CR (1976) Chemical pharmacology of the synapse. Academic, New York, pp 233–430Google Scholar
  91. Vickroy TW, Roeske WR, Yamamura HI (1984) Pharmacological differences between high-affinity muscarinic agonist binding sites of the rat heart and cerebral cortex labelled with (+)-[3H]cis-methyldioxolane. J Pharmacol Exp Ther 229:747–755PubMedGoogle Scholar
  92. Watson M, Roeske WR, Yamamura HI (1982) [3H]pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortex. Life Sci 31:2019–2023PubMedCrossRefGoogle Scholar
  93. Watson M, Roeske WR, Bickroy TW, Smith TL, Akyiama K, Gulya K, Duckies SP, Serra M, Adam A, Nordberg A, Gehlert DR, Wamsley JK, Yamamura HI (1986) Biochemical and functional basis of putative muscarinic receptor subtype and its implications. In: Levine RR, Birdsall NJM, Giachetti A, Hammer R, Iversen LL, Jenden DJ, North RA (eds) Subtypes of muscarinic receptors II. Supplement to Trends in Pharmacological Sciences. Elsevier, Amsterdam, pp 46–55Google Scholar
  94. Weinstein H, Maayani S, Pazhenchevsky B (1983) Multiple actions of phencyclidine: discriminant structure-activity relationships from molecular conformations and assay conditions. Fed Proc 42:2574–2578PubMedGoogle Scholar
  95. Yamamura HI, Snyder SH (1974) Muscarinic cholinergic binding in rat brain. Proc Natl Acad Sci USA 71:1725–1729PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • J. Järv

There are no affiliations available

Personalised recommendations